A carregar...

Recombinant human gamma-interferon in primary hepatocellular carcinoma.

A phase II trial of recombinant human gamma-interferon in the treatment of unresectable primary hepatocellular carcinoma is reported. The trial was terminated prematurely after recruitment of only 7 patients because of unacceptable toxicity, predominantly renal. There was no evidence of response in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Forbes, A, Johnson, P J, Williams, R
Formato: Artigo
Idioma:Inglês
Publicado em: 1985
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1289947/
https://ncbi.nlm.nih.gov/pubmed/2413205
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!